Frequency of JAK2 Mutations in Patients with Suspected Myeloproliferative Neoplasms

被引：0
|
作者：
Judd, A. [1 ]
Chabot-Richards, D. [1 ]
机构：
[1] Univ New Mexico, Albuquerque, NM 87131 USA
来源：
JOURNAL OF MOLECULAR DIAGNOSTICS | 2019年 / 21卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
H005
引用
收藏
页码：1138 / 1138
页数：1
相关论文
共 50 条
  • [31] JAK2 Exon 14 Deletion in Patients with Chronic Myeloproliferative Neoplasms
    Ma, Wanlong
    Kantarjian, Hagop
    Zhang, Xi
    Wang, Xiuqiang
    Zhang, Zhong
    Yeh, Chen-Hsiung
    O'Brien, Susan
    Giles, Francis
    Bruey, Jean Marie
    Albitar, Maher
    PLOS ONE, 2010, 5 (08):
  • [32] JAK2 mutations in myeloproliferative disorders -: Reply
    Kralovics, R
    Cazzola, M
    Skoda, RC
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (13): : 1417 - 1417
  • [33] A role for JAK2 mutations in myeloproliferative diseases
    Morgani, Kelly J.
    Gilliland, D. Galy
    ANNUAL REVIEW OF MEDICINE, 2008, 59 : 213 - 222
  • [34] Why do we see JAK2 exon 12 mutations in myeloproliferative neoplasms?
    Vorechovsky, I.
    Jones, A. V.
    Cross, N. C. P.
    LEUKEMIA, 2013, 27 (09) : 1930 - 1932
  • [35] Why do we see JAK2 exon 12 mutations in myeloproliferative neoplasms?
    I Vorechovsky
    A V Jones
    N C P Cross
    Leukemia, 2013, 27 : 1930 - 1932
  • [36] Classical Philadelphia-negative myeloproliferative neoplasms: focus on mutations and JAK2 inhibitors
    Grzegorz Helbig
    Medical Oncology, 2018, 35
  • [37] INCIDENCE OF NON-CANONICAL MUTATIONS OF JAK2 AND MPL IN CHRONIC MYELOPROLIFERATIVE NEOPLASMS
    Fiaccabrino, S.
    Rotunno, G.
    Calabresi, L.
    Gentili, G.
    Romagnoli, S.
    Mannelli, F.
    Fantoni, D.
    Ravenda, E.
    Vannucchi, A. M.
    Guglielmelli, P.
    HAEMATOLOGICA, 2020, 105 : S67 - S67
  • [38] Classical Philadelphia-negative myeloproliferative neoplasms: focus on mutations and JAK2 inhibitors
    Helbig, Grzegorz
    MEDICAL ONCOLOGY, 2018, 35 (09)
  • [39] The JAK2 46/1 Haplotype Predisposes to Myeloproliferative Neoplasms Characterized by Diverse Mutations
    Cross, Nicholas C. P.
    Campbell, Peter
    Beer, Philip A.
    Schnittger, Susanne
    Vannucchi, Alessandro M.
    Zoi, Katerina
    Percy, Melanie
    McMullin, Mary Frances
    Scott, Linda
    Silver, Richard T.
    Oscier, David
    Harrison, Claire
    Green, Anthony R.
    Chase, Andrew
    BLOOD, 2009, 114 (22) : 180 - 180
  • [40] Mutations in JAK2, MPL and CALR in myeloproliferative neoplasms: High Resolution Melting analysis
    Paola Videla, Yanina
    Quintana, Silvina
    Perez Maturo, Josefina
    Di Geronimo, Vanesa
    Martin, Nazarena
    Pagani, Fernando
    ACTA BIOQUIMICA CLINICA LATINOAMERICANA, 2017, 51 (04): : 629 - 636
12345